Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0322 Transporter Info | ||||
Gene Name | SLC37A1 | ||||
Transporter Name | Glycerol-3-phosphate permease | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
20 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg00549412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:5.33E-09; Z-score:1.54E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg01879556) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:1.18E-08; Z-score:1.93E+00 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg06579790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.51E+00 | Statistic Test | p-value:6.48E-08; Z-score:-1.42E+00 | ||
Methylation in Case |
3.27E-01 (Median) | Methylation in Control | 4.93E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg09546172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.90E+00 | Statistic Test | p-value:1.85E-07; Z-score:-1.86E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 2.95E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg12993026) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:4.23E-07; Z-score:-1.29E+00 | ||
Methylation in Case |
8.10E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg17398613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.32E+00 | Statistic Test | p-value:1.93E-06; Z-score:-1.34E+00 | ||
Methylation in Case |
3.21E-01 (Median) | Methylation in Control | 4.23E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg22599036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:6.35E-06; Z-score:7.76E-01 | ||
Methylation in Case |
8.09E-01 (Median) | Methylation in Control | 6.90E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg23336810) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:7.03E-06; Z-score:1.34E+00 | ||
Methylation in Case |
8.62E-01 (Median) | Methylation in Control | 6.83E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg00288945) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:1.99E-05; Z-score:-1.08E+00 | ||
Methylation in Case |
5.69E-01 (Median) | Methylation in Control | 7.46E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04096368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:5.55E-04; Z-score:-9.61E-01 | ||
Methylation in Case |
6.69E-01 (Median) | Methylation in Control | 7.66E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04192258) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.93E+00 | Statistic Test | p-value:5.99E-04; Z-score:-8.37E-01 | ||
Methylation in Case |
1.26E-01 (Median) | Methylation in Control | 2.42E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:5.60E-03; Z-score:2.81E-01 | ||
Methylation in Case |
1.88E-02 (Median) | Methylation in Control | 1.77E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg08407901) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:6.16E-03; Z-score:-9.02E-01 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 6.57E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:7.23E-03; Z-score:6.31E-02 | ||
Methylation in Case |
8.50E-02 (Median) | Methylation in Control | 8.38E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg11453546) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.25E-02; Z-score:-4.95E-01 | ||
Methylation in Case |
9.58E-01 (Median) | Methylation in Control | 9.67E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon16 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg12409874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:2.76E-02; Z-score:3.37E-01 | ||
Methylation in Case |
3.37E-01 (Median) | Methylation in Control | 3.14E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon17 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg12913778) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:3.17E-02; Z-score:5.11E-01 | ||
Methylation in Case |
5.29E-01 (Median) | Methylation in Control | 4.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon18 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13128052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:3.29E-02; Z-score:5.14E-01 | ||
Methylation in Case |
8.81E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon19 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13960334) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:4.02E-02; Z-score:-2.01E-01 | ||
Methylation in Case |
1.57E-01 (Median) | Methylation in Control | 1.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon20 |
Methylation of SLC37A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg24141725) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.32E+00 | Statistic Test | p-value:1.21E-09; Z-score:-1.49E+00 | ||
Methylation in Case |
4.89E-01 (Median) | Methylation in Control | 6.45E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg23336810) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.41E+00 | Statistic Test | p-value:3.00E-08; Z-score:-7.60E+00 | ||
Methylation in Case |
2.97E-01 (Median) | Methylation in Control | 7.14E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg00549412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.55E+00 | Statistic Test | p-value:7.23E-06; Z-score:-5.05E+00 | ||
Methylation in Case |
4.21E-01 (Median) | Methylation in Control | 6.53E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg09546172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:1.28E-05; Z-score:-3.65E+00 | ||
Methylation in Case |
1.00E-01 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg08599496) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:5.37E-06; Z-score:-4.54E+00 | ||
Methylation in Case |
7.05E-01 (Median) | Methylation in Control | 8.17E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg17218342) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.90E-04; Z-score:-3.78E+00 | ||
Methylation in Case |
7.22E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg13265003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:3.90E-03; Z-score:-2.07E+00 | ||
Methylation in Case |
5.89E-01 (Median) | Methylation in Control | 6.52E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg04096368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.32E+00 | Statistic Test | p-value:1.54E-07; Z-score:-6.03E+00 | ||
Methylation in Case |
5.24E-01 (Median) | Methylation in Control | 6.93E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg12409874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:3.52E-05; Z-score:-4.91E+00 | ||
Methylation in Case |
7.13E-01 (Median) | Methylation in Control | 8.52E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg18478353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:3.52E-03; Z-score:4.04E+00 | ||
Methylation in Case |
7.31E-01 (Median) | Methylation in Control | 6.76E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:7.55E-03; Z-score:-1.02E+00 | ||
Methylation in Case |
8.27E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.69E-02; Z-score:-6.18E-01 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 8.09E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC37A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg00288945) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.14E-02; Z-score:-1.27E+00 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
17 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg17398613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.70E-09; Z-score:1.02E+00 | ||
Methylation in Case |
7.53E-01 (Median) | Methylation in Control | 7.04E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg23336810) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:2.89E-06; Z-score:-1.22E+00 | ||
Methylation in Case |
5.50E-01 (Median) | Methylation in Control | 6.55E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg09546172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.39E+00 | Statistic Test | p-value:4.50E-06; Z-score:-1.10E+00 | ||
Methylation in Case |
9.30E-02 (Median) | Methylation in Control | 1.29E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg13265003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:3.15E-06; Z-score:-6.75E-01 | ||
Methylation in Case |
6.74E-01 (Median) | Methylation in Control | 7.04E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg17218342) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.36E-05; Z-score:-1.20E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg08599496) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:2.28E-02; Z-score:-8.74E-01 | ||
Methylation in Case |
6.64E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg20002045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.59E-02; Z-score:1.12E+00 | ||
Methylation in Case |
8.46E-01 (Median) | Methylation in Control | 8.07E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg04096368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:9.92E-09; Z-score:-1.69E+00 | ||
Methylation in Case |
5.75E-01 (Median) | Methylation in Control | 6.55E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg18478353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.41E-08; Z-score:1.17E+00 | ||
Methylation in Case |
7.23E-01 (Median) | Methylation in Control | 6.76E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg13960334) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:2.98E-06; Z-score:9.40E-01 | ||
Methylation in Case |
9.54E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.03E-05; Z-score:9.00E-01 | ||
Methylation in Case |
7.86E-01 (Median) | Methylation in Control | 7.20E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg12409874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.58E-04; Z-score:-7.28E-01 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg13128052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.12E-03; Z-score:-6.30E-01 | ||
Methylation in Case |
8.18E-01 (Median) | Methylation in Control | 8.33E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:2.45E-02; Z-score:4.64E-01 | ||
Methylation in Case |
7.86E-01 (Median) | Methylation in Control | 7.57E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg12913778) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:2.81E-02; Z-score:5.43E-01 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 4.79E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon16 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg00288945) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.86E-02; Z-score:-2.12E-01 | ||
Methylation in Case |
8.41E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon17 |
Methylation of SLC37A1 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg24141725) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:5.79E-03; Z-score:-4.14E-01 | ||
Methylation in Case |
9.25E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg09546172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.50E+00 | Statistic Test | p-value:4.50E-09; Z-score:-1.36E+00 | ||
Methylation in Case |
5.91E-02 (Median) | Methylation in Control | 8.88E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg23336810) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:5.62E-04; Z-score:-2.38E+00 | ||
Methylation in Case |
6.86E-01 (Median) | Methylation in Control | 8.17E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg22599036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:2.22E-02; Z-score:4.36E-01 | ||
Methylation in Case |
2.13E-02 (Median) | Methylation in Control | 1.94E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:5.13E-03; Z-score:-1.05E+00 | ||
Methylation in Case |
9.33E-01 (Median) | Methylation in Control | 9.43E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg00549412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:2.03E-04; Z-score:-1.03E+00 | ||
Methylation in Case |
6.99E-01 (Median) | Methylation in Control | 7.63E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg06579790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:4.55E-03; Z-score:-5.25E-01 | ||
Methylation in Case |
2.60E-02 (Median) | Methylation in Control | 3.35E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg17398613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.51E-02; Z-score:-3.27E-01 | ||
Methylation in Case |
8.98E-01 (Median) | Methylation in Control | 9.07E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg08599496) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.12E-08; Z-score:-2.10E+00 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg13265003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:3.63E-05; Z-score:-1.15E+00 | ||
Methylation in Case |
7.89E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
TSS200 (cg20002045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:4.77E-02; Z-score:-1.52E-01 | ||
Methylation in Case |
9.35E-01 (Median) | Methylation in Control | 9.37E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:7.53E-05; Z-score:-9.78E-01 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:8.91E-04; Z-score:-6.57E-01 | ||
Methylation in Case |
9.35E-01 (Median) | Methylation in Control | 9.40E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg11453546) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.29E-03; Z-score:-8.77E-01 | ||
Methylation in Case |
6.59E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg04192258) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.51E-03; Z-score:-1.46E-01 | ||
Methylation in Case |
9.68E-01 (Median) | Methylation in Control | 9.69E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg13960334) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.18E-02; Z-score:-5.60E-01 | ||
Methylation in Case |
9.64E-01 (Median) | Methylation in Control | 9.69E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC37A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg18478353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.46E-02; Z-score:-2.41E-01 | ||
Methylation in Case |
8.78E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg23336810) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:4.59E-03; Z-score:9.06E-01 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 7.76E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg08599496) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:8.19E-07; Z-score:-1.47E+00 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 8.37E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg17218342) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.34E-02; Z-score:-2.79E-01 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg13730736) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.71E+00 | Statistic Test | p-value:2.71E-19; Z-score:-3.83E+00 | ||
Methylation in Case |
2.96E-01 (Median) | Methylation in Control | 5.07E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg08033262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.67E+00 | Statistic Test | p-value:1.13E-18; Z-score:-9.23E+00 | ||
Methylation in Case |
5.02E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg13960334) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:1.59E-05; Z-score:9.05E-01 | ||
Methylation in Case |
9.61E-01 (Median) | Methylation in Control | 9.41E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg12409874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.86E-05; Z-score:-1.35E+00 | ||
Methylation in Case |
8.42E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg12913778) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:3.02E-05; Z-score:2.54E+00 | ||
Methylation in Case |
6.37E-01 (Median) | Methylation in Control | 5.65E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg04096368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.96E-04; Z-score:-3.69E-01 | ||
Methylation in Case |
7.94E-01 (Median) | Methylation in Control | 8.08E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg18478353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.95E-03; Z-score:-5.54E-01 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 7.31E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg00288945) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.00E-03; Z-score:-5.45E-01 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 8.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg11453546) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.12E-02; Z-score:5.77E-01 | ||
Methylation in Case |
7.16E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.56E-02; Z-score:4.79E-01 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg04192258) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:1.85E-02; Z-score:-4.29E-01 | ||
Methylation in Case |
9.62E-01 (Median) | Methylation in Control | 9.67E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC37A1 in hepatocellular carcinoma | [ 6 ] | |||
Location |
3'UTR (cg24141725) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.25E-02; Z-score:-4.50E-01 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg00549412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:1.32E-12; Z-score:1.45E+00 | ||
Methylation in Case |
7.80E-01 (Median) | Methylation in Control | 7.11E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg17398613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:4.91E-12; Z-score:1.56E+00 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 7.66E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg13265003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.48E+00 | Statistic Test | p-value:2.83E-17; Z-score:5.44E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 5.55E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
Body (cg18478353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.29E-05; Z-score:7.23E-01 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
Body (cg00288945) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.71E-03; Z-score:-1.09E+00 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 9.47E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
Body (cg12913778) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.73E-03; Z-score:6.52E-01 | ||
Methylation in Case |
6.73E-01 (Median) | Methylation in Control | 6.46E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
Body (cg04096368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.75E-03; Z-score:-1.38E+00 | ||
Methylation in Case |
8.20E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
Body (cg13128052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:5.53E-03; Z-score:-6.34E-01 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in HIV infection | [ 7 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:6.17E-03; Z-score:-7.43E-01 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 8.78E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in lung adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg17398613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:2.86E-03; Z-score:1.68E+00 | ||
Methylation in Case |
7.87E-01 (Median) | Methylation in Control | 7.11E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in lung adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg01879556) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:3.32E-03; Z-score:-1.52E+00 | ||
Methylation in Case |
7.36E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
5'UTR (cg17398613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.16E-08; Z-score:1.36E+00 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 6.93E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
5'UTR (cg09546172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:4.46E-02; Z-score:-5.46E-01 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 1.12E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg17218342) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.61E-04; Z-score:-7.74E-01 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 7.81E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg12409874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:7.03E-09; Z-score:-2.45E+00 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg13128052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.81E-05; Z-score:-1.19E+00 | ||
Methylation in Case |
8.58E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg18478353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:7.53E-05; Z-score:1.24E+00 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 7.59E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg08193480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.51E-04; Z-score:-8.41E-01 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 9.06E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:7.43E-04; Z-score:-5.63E-01 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 9.03E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg13960334) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.32E-03; Z-score:-6.81E-01 | ||
Methylation in Case |
9.35E-01 (Median) | Methylation in Control | 9.45E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg04096368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:3.75E-02; Z-score:-7.88E-01 | ||
Methylation in Case |
3.69E-01 (Median) | Methylation in Control | 4.19E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
5'UTR (cg01879556) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:7.41E-03; Z-score:-7.18E-02 | ||
Methylation in Case |
7.75E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
TSS1500 (cg08599496) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.16E-02; Z-score:-1.39E-01 | ||
Methylation in Case |
8.58E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg11453546) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.97E-02; Z-score:-1.44E-01 | ||
Methylation in Case |
5.48E-01 (Median) | Methylation in Control | 5.56E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg04192258) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.92E-02; Z-score:-1.43E-01 | ||
Methylation in Case |
9.55E-01 (Median) | Methylation in Control | 9.57E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg17816637) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:1.99E-11; Z-score:-2.09E+00 | ||
Methylation in Case |
4.13E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg14777768) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-3.26E+00 | Statistic Test | p-value:2.72E-11; Z-score:-2.46E+00 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 3.65E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg14153919) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:1.38E-10; Z-score:1.99E+00 | ||
Methylation in Case |
6.21E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg13491563) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:2.09E-09; Z-score:-1.32E+00 | ||
Methylation in Case |
5.83E-01 (Median) | Methylation in Control | 6.42E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg22685369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:5.27E-09; Z-score:8.24E-01 | ||
Methylation in Case |
5.24E-02 (Median) | Methylation in Control | 4.17E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg04395689) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.14E+00 | Statistic Test | p-value:1.70E-06; Z-score:1.65E+00 | ||
Methylation in Case |
3.97E-01 (Median) | Methylation in Control | 1.86E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg04433322) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:1.05E-03; Z-score:-1.06E+00 | ||
Methylation in Case |
5.40E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg18865990) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.40E+00 | Statistic Test | p-value:1.77E-11; Z-score:-1.96E+00 | ||
Methylation in Case |
3.79E-01 (Median) | Methylation in Control | 5.31E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg08894629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.39E+00 | Statistic Test | p-value:2.15E-04; Z-score:-8.12E-01 | ||
Methylation in Case |
9.52E-02 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg15507500) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:8.02E-03; Z-score:1.13E+00 | ||
Methylation in Case |
9.28E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg09050775) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:8.70E-03; Z-score:8.40E-01 | ||
Methylation in Case |
5.11E-01 (Median) | Methylation in Control | 4.28E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg21821674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:1.12E-02; Z-score:6.66E-01 | ||
Methylation in Case |
4.92E-01 (Median) | Methylation in Control | 4.30E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:1.14E-02; Z-score:-7.14E-01 | ||
Methylation in Case |
2.47E-01 (Median) | Methylation in Control | 2.94E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC37A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg15999077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.24E-02; Z-score:-4.81E-01 | ||
Methylation in Case |
5.07E-01 (Median) | Methylation in Control | 5.37E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in prostate cancer | [ 12 ] | |||
Location |
TSS1500 (cg15930596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.49E+00 | Statistic Test | p-value:4.01E-02; Z-score:6.00E+00 | ||
Methylation in Case |
1.40E-01 (Median) | Methylation in Control | 9.36E-02 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in prostate cancer | [ 12 ] | |||
Location |
TSS1500 (cg22685369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.35E+00 | Statistic Test | p-value:4.74E-02; Z-score:-3.96E+00 | ||
Methylation in Case |
3.00E-02 (Median) | Methylation in Control | 4.04E-02 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in prostate cancer | [ 12 ] | |||
Location |
Body (cg06903325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:3.57E-02; Z-score:1.29E+00 | ||
Methylation in Case |
9.60E-01 (Median) | Methylation in Control | 9.36E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in colon adenocarcinoma | [ 13 ] | |||
Location |
Body (cg13551505) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:1.12E-07; Z-score:-3.44E+00 | ||
Methylation in Case |
3.96E-01 (Median) | Methylation in Control | 5.70E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in colon adenocarcinoma | [ 13 ] | |||
Location |
Body (cg01082559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.26E-04; Z-score:-2.45E+00 | ||
Methylation in Case |
7.65E-01 (Median) | Methylation in Control | 8.37E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC37A1 in colon adenocarcinoma | [ 13 ] | |||
Location |
Body (cg08581937) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.05E+00 | Statistic Test | p-value:8.16E-04; Z-score:3.57E+00 | ||
Methylation in Case |
2.15E-01 (Median) | Methylation in Control | 7.06E-02 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC37A1 in colon adenocarcinoma | [ 13 ] | |||
Location |
Body (cg24944109) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.32E+00 | Statistic Test | p-value:3.29E-03; Z-score:1.32E+00 | ||
Methylation in Case |
3.09E-01 (Median) | Methylation in Control | 2.34E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC37A1 in panic disorder | [ 14 ] | |||
Location |
Body (cg12409874) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.68E-03; Z-score:6.03E-01 | ||
Methylation in Case |
2.79E+00 (Median) | Methylation in Control | 2.62E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC37A1 in panic disorder | [ 14 ] | |||
Location |
Body (cg08529312) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:2.07E-02; Z-score:5.71E-01 | ||
Methylation in Case |
2.80E+00 (Median) | Methylation in Control | 2.60E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Cerebellar liponeurocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypermethylation of SLC37A1 in cerebellar liponeurocytoma than that in healthy individual | ||||
Studied Phenotype |
Cerebellar liponeurocytoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.007416241; Fold-change:0.236321798; Z-score:1.528412788 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Chordoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypermethylation of SLC37A1 in chordoma than that in healthy individual | ||||
Studied Phenotype |
Chordoma [ICD-11:5A61.0] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.00189494; Fold-change:0.259010689; Z-score:1.485990013 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Craniopharyngioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypermethylation of SLC37A1 in craniopharyngioma than that in healthy individual | ||||
Studied Phenotype |
Craniopharyngioma [ICD-11:2F9A] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.87E-09; Fold-change:0.211924252; Z-score:1.398096231 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Melanocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypermethylation of SLC37A1 in melanocytoma than that in healthy individual | ||||
Studied Phenotype |
Melanocytoma [ICD-11:2F36.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.24E-11; Fold-change:0.277512459; Z-score:2.351163478 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypermethylation of SLC37A1 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:8.75E-20; Fold-change:0.207985187; Z-score:1.519737076 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Chronic myelogenous leukemia |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of SLC37A1 in chronic myelogenous leukaemia than that in healthy individual | ||||
Studied Phenotype |
Chronic myelogenous leukemia [ICD-11:2A20.0] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.014111374; Fold-change:-0.299646286; Z-score:-1.346764594 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Multilayered rosettes embryonal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of SLC37A1 in multilayered rosettes embryonal tumour than that in healthy individual | ||||
Studied Phenotype |
Multilayered rosettes embryonal tumour [ICD-11:2A00.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:6.71E-20; Fold-change:-0.365086283; Z-score:-2.690029482 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
microRNA |
|||||
Unclear Phenotype |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-19a directly targets SLC37A1 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-19a | miRNA Mature ID | miR-19a-3p | ||
miRNA Sequence |
UGUGCAAAUCUAUGCAAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-19b directly targets SLC37A1 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-19b | miRNA Mature ID | miR-19b-3p | ||
miRNA Sequence |
UGUGCAAAUCCAUGCAAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-335 directly targets SLC37A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.